If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGowin New Energy Group Limited Regulatory News (GWIN.PL)

Share Price Information for Gowin New Energy Group Limited (GWIN.PL)

Share Price is delayed by 15 minutes
Get Live Data
0.075    0.00 (0.00%)
Bid:
0.05
Ask:
0.10
Spread: 0.05 (100.00%)
Market Cap: £217.50k
GWIN.PL Live PriceLast checked at - Aquis Stock Exchange

Intraday Gowin New Energy Group Limited Share Chart

Director Appointment

4 Nov 2024 13:59

RNS Number : 8590K
Gowin New Energy Group Limited
04 November 2024
 

04 November 2024

 

Gowin New Energy Group Limited

("Gowin" or the "Company")

Director Appointment

 

Gowin New Energy Group Limited is pleased to announce the appointment of Mr. Chien Chih-Peng as a Director of the Company, with immediate effect.

 

Mr Chien has served as the sole Director and owner of Chan Sheng International Co Ltd ("Chan Sheng") since 2022, following his tenure as General Manager of the company since its establishment in 2016. He has 32 years of experience in the travel industry and is currently responsible for leading his team in strategic planning, market research and project management. Chan Sheng specialises in providing travel and tourism products and sales services across Europe, Australia, the Middle East, Southeast Asia and mainland China. Mr. Chien is also General Manager of its sister company, Chan Sheng International Travel Co Ltd, which was established in 2005.

 

 

Garry Willinge, Non-Executive Chairman of the Company, said:

 

"I am delighted to welcome Chien Chih-Peng to the Company management and to the board of directors. He is a well-known businessman in Taiwan and has particular skills and experience that should enable the Company develop new business strategies; he also has governance experience that will add value to the board."

 

Disclosures required pursuant to Rule 4.9 of the Aquis Growth Market Access Rulebook

Mr. Chien Chih-Peng has no direct or indirect interest in the Company's issued share capital.

The names of all companies of which Mr. Chien Chih-Peng has been a director at any time in the previous five years are set out below:

Current directorships or partnerships

Previous directorships or partnerships

Chan Sheng International Co., Ltd.

Chan sheng International Travel Agency Co., Ltd

 

 

Except as set out above, there is no further information regarding Mr. Chien Chih-Peng that is required to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.

The directors of Gowin accept responsibility for this announcement.

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).

 

For further information please visit company's website at  www.gowingrp.com or contact the following:

Gowin New Energy Group Limited 

Garry Willinge

Tel: +852 9100 9972

 

Novum Securities Limited

AQSE Corporate Adviser

David Coffman / George Duxberry

Tel: +44 (0)207 399 9400

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXBIBJTMTAMBLI
Date   Source Headline
3rd Jul 20261:05 pmRNSShareholder Loan
30th Jun 20267:00 amRNSAnnual Results for the year ended 31 December 2025
5th May 20267:00 amRNSDirector Loan
7th Apr 202611:01 amRNSDirector Loan
12th Feb 20269:59 amRNSDirector Loan
27th Jan 20261:07 pmRNSDirector's Loan
6th Jan 20269:06 amRNSLoan Agreement
30th Dec 202512:40 pmRNSBoard Changes
30th Dec 202512:40 pmRNSBoard Changes
29th Dec 20259:53 amRNSLoan Agreement
29th Dec 20259:53 amRNSLoan Agreement
10th Dec 20251:25 pmRNSResult of AGM
17th Nov 20253:48 pmRNSNotice of AGM
24th Oct 20258:24 amRNSBoard Changes
8th Oct 20259:29 amRNSExtension of Shareholder Loan Agreements
29th Sep 202512:17 pmRNSInterim Results for Six Months Ended 30 June 2025
26th Sep 202512:00 pmRNSDirector Loan
5th Sep 202510:53 amRNSDirector's Loan
18th Jul 202511:30 amRNSDirector Loan £25k
27th Jun 202510:04 amRNSFinal Results
9th May 20259:35 amRNSDirector Loan £25k & NTD$300k
12th Feb 20255:19 pmRNSHolding(s) in Company
12th Feb 20255:13 pmRNSDirector/PDMR Shareholding
23rd Jan 20259:07 amRNSDirector Loan
21st Jan 20259:56 amRNSHolding(s) in Company
21st Jan 20259:52 amRNSHolding(s) in Company
21st Jan 20259:47 amRNSDirector/PDMR Shareholding
7th Nov 20249:26 amRNSDirector Loans
4th Nov 20241:59 pmRNSDirector Appointment
4th Nov 20248:46 amRNSResult of AGM
10th Oct 20249:09 amRNSNotice of AGM
26th Sep 20247:00 amRNSInterim Results
19th Jul 20241:06 pmRNSDirector Loan £50k
25th Jun 20247:00 amRNSAnnual Results for the year ended 31 December 2023
24th May 202410:13 amRNSDirector Loan 500k TWD
30th Apr 20249:14 amRNSDirector Loan £20k
8th Apr 20249:36 amRNSDirector Loan
23rd Jan 20249:23 amRNSDirector Loan £30k
2nd Jan 20247:00 amRNSDirector Loan 300K NTD
24th Nov 20239:34 amRNSDirector Loan £25k
16th Oct 20239:26 amRNSDirector Loan £30k
28th Sep 20234:15 pmRNSInterim Results for Six Months Ended 30 June 2023
28th Sep 20233:27 pmRNSDirector Loan £15k
31st Aug 202310:20 amRNSResult of AGM
14th Aug 202310:37 amRNSDirector Loan £15k
31st Jul 20239:16 amRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.